Rani Therapeutics Holdings earnings were -$29.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest RANI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$7.3M, down 18.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RANI reported annual earnings of -$30.0M, with -11.6% growth.
Rani Therapeutics Holdings Earnings Reports & History FAQ
What were Rani Therapeutics Holdings's earnings last quarter?
On RANI's earnings call on Invalid Date, Rani Therapeutics Holdings (NASDAQ: RANI) reported Q1 2025 earnings per share (EPS) of -$0.22, up 24.14% year over year. Total RANI earnings for the quarter were -$7.26 million. In the same quarter last year, Rani Therapeutics Holdings's earnings per share (EPS) was -$0.29.
Is Rani Therapeutics Holdings profitable or losing money?
As of the last Rani Therapeutics Holdings earnings report, Rani Therapeutics Holdings is currently losing money. Rani Therapeutics Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$29.80 million, a 9.92% decrease year over year.
What was RANI's earnings growth in the past year?
As of Rani Therapeutics Holdings's earnings date in Invalid Date, Rani Therapeutics Holdings's earnings has grown year over year. RANI earnings in the past year totalled -$29.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.